Eco‐friendly Synthesis and Molecular Modelling of 2‐Phenylimidazo[1,2‐b]pyridazine Derivatives: In Vitro and In Vivo Studies for Lead Optimization
ChemMedChem · 2025
DOI: 10.1002/cmdc.202400721 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemMedChem, 2025. Verfasst von Marica Erminia Schiano und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, "Federico II" University of Napoli, Via Domenico Montesano 49, 80131, Napoli, Italy. Hauptthemen laut MEDLINE: Pyridazines, Anticonvulsants, Seizures, Neuroprotective Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 60 Literaturangaben.
Abstract (Originalsprache)
7‐methyl‐2‐phenylimidazo[1,2‐b]pyridazin‐3‐carboxylic acid (DM1) and 6‐methoxy‐2‐phenylimidazo[1,2‐b]pyridazin‐3‐carboxylic acid (DM2) have been shown to act as human (h) Cav 3.1 voltage‐gated calcium channel blockers with promising in vivo anti‐absence activity, positioning them as potential antiepileptic drugs. The primary aim of this work was to develop cost‐effective and environmentally friendly synthetic procedures for preparing 2‐phenylimidazo[1,2‐b]pyridazine derivatives. After optimizing the synthesis of this compound class using efficient and green techniques such as microwaves and ultrasound irradiation, we further evaluated the antiepileptic effects of DM1 and DM2 in two animal models: CD‐1 ICR mice after pentylenetetrazol administration and DBA/2 mice with seizures induced by audiogenic stimuli. Their neuroprotective effect against oxidative stress were assessed using C6 rat brain glioma cells. DM1 and DM2 exhibited potent anti‐seizure effects in both animal models and demonstrated significant in vitro neuroprotective activity by reducing reactive oxygen species release. To lay the groundwork for the future rational optimization of this promising class of compounds, the molecular bases of DM1 and DM2 activity were investigated by modelling their interaction with hCav 3.1 channels. The calculated binding modes of DM1 and DM2 to hCav 3.1 channels partially mirrored that of the selective Cav 3.1 blocker Z944, paving the way for future lead optimization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, "Federico II" University of Napoli, Via Domenico Montesano 49, 80131, Napoli, Italy.
- Department of Drug Science and Technology, University of Torino, 10125, Torino, Italy.
- Department of Science of Health, University "Magna Graecia" of Catanzaro, 88100, Catanzaro, Italy.
ORCID-Profile: Marica Erminia Schiano, Chiara Billi, Giorgio Grillo, Oleh Tkachuk, Stefania Albrizio, Marco Persico, Federica Sodano, Caterina Fattorusso
Zitieren
APA
Schiano, M. E., Billi, C., Grillo, G., Tkachuk, O., De Caro, C., Russo, E., Comella, F., Meli, R., Frecentese, F., Santagada, V., Cinque, P., Albrizio, S., Persico, M., Sodano, F., Fattorusso, C., & Rimoli, M. G. (2025). Eco‐friendly Synthesis and Molecular Modelling of 2‐Phenylimidazo[1,2‐b]pyridazine Derivatives: In Vitro and In Vivo Studies for Lead Optimization. ChemMedChem. https://doi.org/10.1002/cmdc.202400721
Vancouver
Schiano ME, Billi C, Grillo G, Tkachuk O, De Caro C, Russo E, et al. Eco‐friendly Synthesis and Molecular Modelling of 2‐Phenylimidazo[1,2‐b]pyridazine Derivatives: In Vitro and In Vivo Studies for Lead Optimization. ChemMedChem. 2025. doi:10.1002/cmdc.202400721
BibTeX
@article{Schiano2025,
author = {Schiano, Marica Erminia and Billi, Chiara and Grillo, Giorgio and Tkachuk, Oleh and De Caro, Carmen and Russo, Emilio and Comella, Federica and Meli, Rosaria and Frecentese, Francesco and Santagada, Vincenzo and Cinque, Pierfrancesco and Albrizio, Stefania and Persico, Marco and Sodano, Federica and Fattorusso, Caterina and Rimoli, Maria Grazia},
title = {Eco‐friendly Synthesis and Molecular Modelling of 2‐Phenylimidazo[1,2‐b]pyridazine Derivatives: In Vitro and In Vivo Studies for Lead Optimization},
journal = {ChemMedChem},
year = {2025},
doi = {10.1002/cmdc.202400721}
}
EUVIMED